Assessment interocular symmetry of peripapillary vessel density in young myopes with optical coherence tomographic angiography.

Authors:
Liu L; Deng ML; Li M; Xu D; Feng L and 2 more

Journal:
Int Ophthalmol

Publication Year: 2023

DOI:
10.1007/s10792-023-02737-8

PMCID:
PMC10504110

PMID:
37515664

Journal Information

Full Title: Int Ophthalmol

Abbreviation: Int Ophthalmol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Ophthalmology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of interestThe authors have no conflicts of interest to declare. Ethical approvalThis study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Shanghai Tenth People’s Hospital (No: 20kt168) and was registered at Chinese Clinical Trial Registry (No: ChiCTR2000035768). Consent to participateInformed consent was obtained from all individual participants included in the study. Consent to publishThe participant has consented to the submission of the case report to the journal. Human or animal rightsOur research involving human participants and no animals. Conflict of interest The authors have no conflicts of interest to declare."

Evidence found in paper:

"Funding This study was supported by grants from the Clinical Research Plan of SHDC (No. SHDC2020CR1043B-009), and Clinical research project of Shanghai Tenth People’s Hospital (NO. SHYCS08), National Natural Science Foundation of China Grants (82171077) and The Clinical Research Shanghai Municipal Health Commission (202240131)."

Evidence found in paper:

"We performed a cross-sectional observational study on myopic eyes of young Chinese. The study was approved by the Ethics Committee of Shanghai Tenth People’s Hospital (No: 20KT168) and was registered at Chinese Clinical Trial Registry (no: ChiCTR2000035768). A total of 174 eyes of 87 consecutive myopic candidates examined at Shanghai Tenth People’s Hospital were enrolled from September 2020 to August 2021. The median age was 25 years (range, 18–35 years). The average spherical equivalent (SE) was − 4.84 D (SD 2.31D, range − 0.5D to − 10.625D), and the average axial length (AL) was 25.56 ± 1.21 mm (range, 22.86 to 28.49 mm). According to SE, the subjects were divided into three groups: mild myopia group (− 0.5 D ≤ SE < − 3.0 D), moderate myopia group (− 3 D ≤ SE < -6.0 D and high myopia group (SE ≥ − 6.0 D). Myopia was mild in 48 eyes with a mean SE of − 2.12D (SD 0.66D), moderate in 66 eyes with a mean SE of − 4.50D (SD 0.87D) and high in 60 eyes with a mean SE of − 7.39D (SD 1.30D). None had a history of ocular surgery, ocular trauma, or systemic or ocular health abnormality. The demographic and ophthalmic characteristics of the three groups are summarized in Table . The study adhered to the tenets of the Declaration of Helsinki, and written informed consent was obtained by all subjects. Declarations: Conflict of interestThe authors have no conflicts of interest to declare.: Ethical approvalThis study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Shanghai Tenth People’s Hospital (No: 20kt168) and was registered at Chinese Clinical Trial Registry (No: ChiCTR2000035768).: Consent to participateInformed consent was obtained from all individual participants included in the study.: Consent to publishThe participant has consented to the submission of the case report to the journal.: Human or animal rightsOur research involving human participants and no animals. Ethical approval: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Shanghai Tenth People’s Hospital (No: 20kt168) and was registered at Chinese Clinical Trial Registry (No: ChiCTR2000035768)."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025